Clinical Trials Logo

Convergence Insufficiency clinical trials

View clinical trials related to Convergence Insufficiency.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT02207517 Active, not recruiting - Clinical trials for Convergence Insufficiency

Office-based Vision Therapy for Improving Reading and Attention in Children With Convergence Insufficiency

CITT-ART
Start date: May 2014
Phase: Phase 3
Study type: Interventional

CITT-ART is a multicenter study (8 locations around the United States) of 324 children ages 9 to <14 years with symptomatic convergence insufficiency (CI). The purpose of this study is to see if office-based therapy for convergence insufficiency (CI) improves reading ability and attention. CI is an eye-teaming problem where the eyes would like to drift outward when reading or doing close work. When eyes drift out, double vision can happen. To prevent double vision one must use extra effort to keep the eyes from going out. This extra effort can cause symptoms that can interfere with reading and working comfortably at near. These symptoms often include eyestrain, blurred vision, headaches, double vision, and loss of place when reading or performing tasks at near. In a prior study we found that therapy improves these symptoms. In this study we are looking at whether the therapy improves reading and attention

NCT ID: NCT00338611 Active, not recruiting - Clinical trials for Convergence Insufficiency

Convergence Insufficiency Treatment Trial (CITT)

Start date: July 2005
Phase: Phase 3
Study type: Interventional

The purposes of the CITT are: - To determine whether Home-based Pencil Push-up therapy, Home-based Pencil Push-ups with Computer Vision Therapy/Orthoptics or Office-based VT/Orthoptics more effective than placebo treatment, and whether there are differences between the three treatments in improving subject symptoms and signs. - To evaluate whether improvements in outcome measures are still present after one year of observation.